Arong, Arjay R.
HRN: 02-27-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2025
METRONIDAZOLE 500MG (TAB)
08/18/2025
08/24/2025
IV
500 Mg
Q 8 Hours
Amebiasis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: